Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia "XANAP"


Phase N/A Results N/A

Summary of Purpose

This is an international observational study in patients with non-valvular atrial fibrillation who are prescribed rivaroxaban under routine treatment conditions to prevent stroke or non-central nervous system systemic embolism.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 September 2017.

13 Jan 2013 13 Dec 2012 12 Oct 2015 12 Oct 2015 1 Sep 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample